Literature DB >> 12021246

Myeloperoxidase produces nitrating oxidants in vivo.

Joseph P Gaut1, Jaeman Byun, Hung D Tran, Wendy M Lauber, James A Carroll, Richard S Hotchkiss, Abderrazzaq Belaaouaj, Jay W Heinecke.   

Abstract

Despite intense interest in pathways that generate reactive nitrogen species, the physiologically relevant mechanisms for inflammatory tissue injury remain poorly understood. One possible mediator is myeloperoxidase, a major constituent of neutrophils, monocytes, and some populations of macrophages. The enzyme uses hydrogen peroxide and nitrite to generate 3-nitrotyrosine in vitro. To determine whether myeloperoxidase produces nitrating intermediates in vivo, we used isotope dilution gas chromatography/mass spectrometry to quantify 3-nitrotyrosine in two models of peritoneal inflammation: mice infected with Klebsiella pneumoniae and mice subjected to cecal ligation and puncture. Both models developed an intense neutrophil inflammatory response, and the inflammatory fluid contained markedly elevated levels of 3-chlorotyrosine, a marker of myeloperoxidase action. In striking contrast, 3-nitrotyrosine levels rose only in the mice infected with K. pneumoniae. Levels of total nitrite and nitrate were 20-fold higher in mice injected with K. pneumoniae than in mice subjected to cecal ligation and puncture. Levels of 3-nitrotyrosine failed to increase in mice infected with K. pneumoniae that lacked functional myeloperoxidase. Our observations provide strong evidence that myeloperoxidase generates reactive nitrogen species in vivo and that it operates in this fashion only when nitrite and nitrate become available. This article was published online in advance of the print edition. The date of publication is available from the JCI website, http://www.jci.org.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021246      PMCID: PMC150982          DOI: 10.1172/JCI15021

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry.

Authors:  Joseph P Gaut; Jaeman Byun; Hung D Tran; Jay W Heinecke
Journal:  Anal Biochem       Date:  2002-01-15       Impact factor: 3.365

Review 2.  The L-arginine-nitric oxide pathway.

Authors:  S Moncada; A Higgs
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

3.  Studies on the chlorinating activity of myeloperoxidase.

Authors:  J E Harrison; J Schultz
Journal:  J Biol Chem       Date:  1976-03-10       Impact factor: 5.157

4.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins.

Authors:  H Ohshima; M Friesen; I Brouet; H Bartsch
Journal:  Food Chem Toxicol       Date:  1990-09       Impact factor: 6.023

6.  Assessment of chlorination by human neutrophils.

Authors:  C S Foote; T E Goyne; R I Lehrer
Journal:  Nature       Date:  1983-02-24       Impact factor: 49.962

7.  Nitrite production by stimulated human polymorphonuclear leukocytes supplemented with azide and catalase.

Authors:  S J Klebanoff; C F Nathan
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

8.  Reactive nitrogen intermediates and antimicrobial activity: role of nitrite.

Authors:  S J Klebanoff
Journal:  Free Radic Biol Med       Date:  1993-04       Impact factor: 7.376

9.  Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages.

Authors:  J W Heinecke; W Li; H L Daehnke; J A Goldstein
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

10.  Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases.

Authors:  A J Farrell; D R Blake; R M Palmer; S Moncada
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

View more
  61 in total

1.  Whence nitrotyrosine?

Authors:  James K Hurst
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Dennis P Riley; Jay L Zweier; Christoph Thiemermann; Zhi-Qiang Wang; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 3.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

4.  Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing Ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy.

Authors:  J-Ph Lejeune; D Serteyn; M Gangl; N Schneider; G Deby-Dupont; M Deberg; Y Henrotin
Journal:  Vet Res Commun       Date:  2007-01-24       Impact factor: 2.459

5.  The effect of vitamin A pretreatment on radiation induced alteration in neutrophil functions.

Authors:  Barbaros Balabanli; Nurten Türközkan; Sema Balabanli; Husamettin Erdamar; Müge Akmansu
Journal:  Mol Cell Biochem       Date:  2006-02-14       Impact factor: 3.396

Review 6.  The role of myeloperoxidase in HDL oxidation and atherogenesis.

Authors:  Jay W Heinecke
Journal:  Curr Atheroscler Rep       Date:  2007-10       Impact factor: 5.113

7.  Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins.

Authors:  Giorgio Cavigiolio; Ethan G Geier; Baohai Shao; Jay W Heinecke; Michael N Oda
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

8.  Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW-85 in interleukin-2 induced toxicity.

Authors:  Dirk M Maybauer; Marc O Maybauer; Csaba Szabó; Martin Westphal; Lillian D Traber; Perenlei Enkhbaatar; Kanneganti G K Murthy; Yoshimitsu Nakano; Andrew L Salzman; David N Herndon; Daniel L Traber
Journal:  Biochem Biophys Res Commun       Date:  2008-10-23       Impact factor: 3.575

Review 9.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

10.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

Authors:  Lemin Zheng; Benedicta Nukuna; Marie-Luise Brennan; Mingjiang Sun; Marlene Goormastic; Megan Settle; Dave Schmitt; Xiaoming Fu; Leonor Thomson; Paul L Fox; Harry Ischiropoulos; Jonathan D Smith; Michael Kinter; Stanley L Hazen
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.